Skip to main content
Log in

Splenectomy for Acute or Persistent Immune Thrombocytopenia: an Overkill or a Necessity

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Splenectomy is usually deferred for the first 12 months of onset of immune thrombocytopenia (ITP) because patients may have spontaneous remission. However, in patients with failed medical management, splenectomy is a valuable treatment option. This study aimed to evaluate the role of splenectomy in patients with persistent ITP with failed medical management at a tertiary care center. A retrospective review of records of all patients who underwent splenectomy for ITP between January 2010 and December 2019 was done. We identified the patients with primary ITP refractory to medical management who were referred from hematology to our department for splenectomy and their clinical course was evaluated. Most of the patients were females (14/20, 70%), and the mean age of patients in our series was 33.7 ± 11.1 years. Skin petechiae and mucosal bleeding were the most common presenting symptoms. Mean pre-operative platelet count was 20,079 ± 11,644/μL. After a trial of medical management for a mean duration of 6.7 ± 3.6 months, patients were planned for splenectomy. All patients improved symptomatically after surgery. A significant increase in platelet count was observed (mean: 80,290 ± 75,327/μL). Splenectomy (either open or laparoscopic approach) is a safe and very good option in patients with new onset and persistent ITP refractory to medical management with favorable outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Kaznelson P (1916) Verschwinden der hamorrhagischen diathese bei einem falle von essentieller thrombopenie (frank) nach milzexstiparation : Splenogene thrombolytische purpura. Wien Klin Wochenschr 29:1451

    Google Scholar 

  2. Chaturvedi S, Arnold DM, McCrae KR (2018) Splenectomy for immune thrombocytopenia: down but not out. Blood 131:1172–1182. https://doi.org/10.1182/blood-2017-09-742353

    Article  CAS  Google Scholar 

  3. Neunert C, Terrell DR, Arnold DM et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3:3829–3866. https://doi.org/10.1182/bloodadvances.2019000966

    Article  CAS  Google Scholar 

  4. Provan D, Arnold DM, Bussel JB et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3:3780–3817. https://doi.org/10.1182/bloodadvances.2019000812

    Article  CAS  Google Scholar 

  5. Rodeghiero F, Michel M, Gernsheimer T et al (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 121:2596–2606. https://doi.org/10.1182/blood-2012-07-442392

    Article  CAS  Google Scholar 

  6. British Committee for Standards in Haematology General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120:574–596. https://doi.org/10.1046/j.1365-2141.2003.04131.x

    Article  Google Scholar 

  7. Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549–2554. https://doi.org/10.1182/blood.V97.9.2549

    Article  CAS  Google Scholar 

  8. Akwari OE, Itani KM, Coleman RE, Rosse WF (1987) Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg 206:529–541

    Article  CAS  Google Scholar 

  9. Cola B, Tonielli E, Sacco S et al (1986) Surgical treatment of chronic idiopathic thrombocytopenic purpura: results in 107 cases. Int Surg 71:195–198

    CAS  Google Scholar 

  10. Harold KL, Schlinkert RT, Mann DK et al (1999) Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura. Mayo Clin Proc 74:37–39. https://doi.org/10.4065/74.1.37

    Article  CAS  Google Scholar 

  11. Katkhouda N, Hurwitz MB, Rivera RT et al (1998) Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 228:568–578. https://doi.org/10.1097/00000658-199810000-00013

    Article  CAS  Google Scholar 

  12. Watson DI, Coventry BJ, Chin T et al (1997) Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery 121:18–22. https://doi.org/10.1016/S0039-6060(97)90177-X

    Article  CAS  Google Scholar 

  13. Neylon AJ, Saunders PWG, Howard MR et al (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122:966–974. https://doi.org/10.1046/j.1365-2141.2003.04547.x

    Article  Google Scholar 

  14. Thai L-H, Mahévas M, Roudot-Thoraval F et al (2016) Long-term complications of splenectomy in adult immune thrombocytopenia. Medicine (Baltimore) 95:e5098. https://doi.org/10.1097/MD.0000000000005098

    Article  CAS  Google Scholar 

  15. Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood 64:1179–1183. https://doi.org/10.1182/blood.V64.6.1179.1179

    Article  CAS  Google Scholar 

  16. Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104:2623–2634. https://doi.org/10.1182/blood-2004-03-1168

    Article  CAS  Google Scholar 

  17. Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81:312–319. https://doi.org/10.1007/s00277-002-0461-8

    Article  CAS  Google Scholar 

  18. Duperier T, Brody F, Felsher J et al (2004) Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg 139:61–66. https://doi.org/10.1001/archsurg.139.1.61

    Article  Google Scholar 

  19. Mintz SJ, Petersen SR, Cheson B et al (1981) Splenectomy for immune thrombocytopenic purpura. Arch Surg 116:645–650. https://doi.org/10.1001/archsurg.1981.01380170121022

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yashwant Singh Rathore.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaturvedi, A., Baig, K., Rathore, Y. et al. Splenectomy for Acute or Persistent Immune Thrombocytopenia: an Overkill or a Necessity. Indian J Surg 84, 1205–1210 (2022). https://doi.org/10.1007/s12262-021-03206-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-021-03206-1

Keywords

Navigation